Claire Poll - 20 Oct 2023 Form 4 Insider Report for Verona Pharma plc (VRNA)

Role
General Counsel
Signature
/s/ Claire Poll
Issuer symbol
VRNA
Transactions as of
20 Oct 2023
Net transactions value
$0
Form type
4
Filing time
24 Oct 2023, 16:06:03 UTC
Previous filing
07 Aug 2023
Next filing
03 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRNA Ordinary Shares Award $0 +200,000 +11% $0.000000 2,017,391 20 Oct 2023 Direct F1, F2, F3
holding VRNA Ordinary Shares 864,232 20 Oct 2023 By Trust F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
F2 Represents an award of Restricted Share Units ("RSUs"), each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer. The RSUs vest over four years, with 50,000 RSUs vesting on November 1, 2024 and the balance vesting in 12 equal quarterly installments thereafter.
F3 Consists of (i) 1,671,672 Ordinary Shares underlying RSUs (which are represented by 208,959 ADSs); (ii) 345,712 Ordinary Shares underlying 43,214 ADSs and (iii) 7 Ordinary Shares.
F4 Held by a family trust of which (a) the Reporting Person and spouse are trustees and (b) the Reporting Person and members of her immediate family are the sole beneficiaries of the trust.